Trials / Completed
CompletedNCT00136968
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the amount of voriconazole in the brain by fluorine-magnetic resonance spectroscopy (MRS) and to compare brain levels to plasma levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Voriconazole |
Timeline
- Start date
- 2005-04-01
- Completion
- 2005-05-01
- First posted
- 2005-08-29
- Last updated
- 2009-03-12
Source: ClinicalTrials.gov record NCT00136968. Inclusion in this directory is not an endorsement.